ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α
ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α
复制标题
DOI:
10.1096/fj.202001687r
复制
发表时间:
2021-04-01
期刊:
影响因子:
4.8
通讯作者:
Kunisawa, Jun
中科院分区:
文献类型:
--
作者:
Saika, Azusa;Nagatake, Takahiro;Kunisawa, Jun
omega 3 fatty acids show potent bioactivities via conversion into lipid mediators; therefore, metabolism of dietary lipids is a critical determinant in the properties of omega 3 fatty acids in the control of allergic inflammatory diseases. However, metabolic progression of omega 3 fatty acids in the skin and their roles in the regulation of skin inflammation remains to be clarified. In this study, we found that 12-hydroxyeicosapentaenoic acid (12-HEPE), which is a 12-lipoxygenase metabolite of eicosapentaenoic acid, was the prominent metabolite accumulated in the skin of mice fed omega 3 fatty acid-rich linseed oil. Consistently, the gene expression levels of Alox12 and Alox12b, which encode proteins involved in the generation of 12-HEPE, were much higher in the skin than in the other tissues (eg, gut). We also found that the topical application of 12-HEPE inhibited the inflammation associated with contact hypersensitivity by inhibiting neutrophil infiltration into the skin. In human keratinocytes in vitro, 12-HEPE inhibited the expression of two genes encoding neutrophil chemoattractants, CXCL1 and CXCL2, via retinoid X receptor alpha. Together, the present results demonstrate that the metabolic progression of dietary omega 3 fatty acids differs in different organs, and identify 12-HEPE as the dominant omega 3 fatty acid metabolite in the skin.